Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

494
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
494
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

898
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
898
Causality in Epidemiology01:21

Causality in Epidemiology

1.8K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.8K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.5K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.5K
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

1.4K
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
1.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

508
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
508

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Event-Related Treatment Modifications in Exposure-Response Analyses of Repeated Time-to-Event Data.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Latent Variable Indirect Response Modeling of Cendakimab Exposure-Response for Longitudinal Dysphagia Days Using a Combined Uniform-Binomial Likelihood Framework.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Tutorial on Causal Mediation Analysis for Pharmacometricians.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Integrating MBMA and QSP to Identify Key Covariates and Predict Treatment Outcomes in Relapsed/Refractory Multiple Myeloma.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Building Hybrid Pharmacometric-Machine Learning Models in Oncology Drug Development: Current State and Recommendations.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Model-Informed Drug Development-Based Bridging from Subcutaneous to Intravenous Secukinumab Dosing: Approval in Psoriatic Arthritis and Axial Spondyloarthritis.

Clinical pharmacology and therapeutics·2025

Related Experiment Video

Updated: Mar 4, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Causal Directed Acyclic Graphs to Mitigate Confounding Bias in Exposure-Response Analyses.

Sebastiaan C Goulooze1, Camille Vong2, Chuanpu Hu3

  • 1LAP&P Consultants BV, Leiden, the Netherlands.

CPT: Pharmacometrics & Systems Pharmacology
|March 2, 2026
PubMed
Summary
This summary is machine-generated.

Estimating drug exposure-response relationships is vital for personalized medicine but often confounded. Causal inference and directed acyclic graphs (DAGs) offer solutions for accurate oncology drug analysis.

Keywords:
biascausal inferenceconfoundingdirected acyclic graphsexposure‐responseoncology

More Related Videos

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.7K

Related Experiment Videos

Last Updated: Mar 4, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

11.7K

Area of Science:

  • Pharmacometrics
  • Causal Inference
  • Oncology Drug Development

Background:

  • Exposure-response (E-R) analysis is crucial for drug development and treatment individualization.
  • Estimating the causal effect of drug exposure on response can be challenging due to confounding.
  • Confounding can obscure the true relationship between drug exposure and patient outcomes.

Purpose of the Study:

  • To examine confounding in E-R analyses within oncology using causal inference.
  • To demonstrate the utility of causal directed acyclic graphs (DAGs) in understanding confounding challenges.
  • To identify potential solutions for mitigating confounding in E-R analyses in oncology.

Main Methods:

  • Application of causal inference principles to E-R analysis.
  • Utilizing causal directed acyclic graphs (DAGs) to visualize and analyze confounding factors.
  • Review and perspective on existing methodologies and challenges in oncology E-R analysis.

Main Results:

  • Causal inference provides a framework to identify and address confounding in E-R relationships.
  • DAGs visually represent complex causal pathways, aiding in the understanding of confounding.
  • The proposed causal approach can lead to more reliable estimation of drug effects.

Conclusions:

  • Causal inference and DAGs are powerful tools for navigating confounding in oncology E-R analysis.
  • Adopting causal methods can improve the accuracy of drug effect estimation.
  • This approach supports more robust drug development and personalized treatment strategies.